Bizarre Patents
Apparatus for Simulating a High Five
A self-righting hand-arm configuration which is adapted to pivot when struck by a user, thereby simulating a "high five."
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6472522 | Purification of oligomers using dual-end selection Oligomers are prepared substantially free of error sequences by sequentially adding monomers to a growing chain bound to a support through a first selectably cleavable linkage, a first capture moiety and a second selectably cleavable linkage. At the compl... | 10/29/2002 |
| 6414037 | Pharmaceutical formulations of resveratrol and methods of use thereof A method is provided for preventing or treating skin conditions, disorders or diseases, such as may be associated with or caused by inflammation, sun damage or natural aging. The method involves administration, preferably topical administration, of an act... | 07/02/2002 |
| 6369114 | Administration of an 댒-adrenergic receptor agonist to enhance cardiopulmonary resuscitation Methods, formulations and kits are described for resuscitating a patient suffering from cardiac arrest, for enhancing the efficacy of cardiopulmonary resuscitation, for treating post-resuscitation hypotension, and for reducing the incidence of ventricular... | 04/09/2002 |
| 6307057 | Acid addition salts of imidazolidinones as reaction catalysts Acid addition salts of imidazolidinones are provided as catalysts for transforming a functional group within a first reactant by reaction with a second reactant. Exemplary first reactants are ,ଲ-unsaturated carbonyl compounds such as ,... | 10/23/2001 |
| 6306436 | Stabilized, acid-free formulation for sustained release of bupropion hydrochloride Stabilized bupropion hydrochloride pharmaceutical compositions are disclosed that are free of acid additives and provide for a sustained release of the bupropion hydrochloride. The particulate bupropion hydrochloride may be coated with a membrane coating ... | 10/23/2001 |
| 6291023 | Method and composition for textile printing The present invention features novel methods and compositions for coating textile substrates, wherein the coating compositions are composed of a coating agent selected from one of (a) an azetidinium polymer, (b) a guanidine polymer, (c) a mixture of an az... | 09/18/2001 |
| 6288184 | Hydrolytically degradable olefin copolymers Hydrolytically degradable olefin copolymers, such as ethylene copolymers, contain a hydrolyzable component in the backbone that allows the copolymer to be broken down into dispersable fragments upon exposure to aqueous conditions. The copolymers are prepa... | 09/11/2001 |
| 6287600 | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin A pharmaceutical composition is provided for the oral administration of an NSAlD and a prostaglandin. The composition is a solid dosage form wherein the NSAID is enterically coated and the prostaglandin is present along with an effective stabilizing amoun... | 09/11/2001 |
| 6232462 | Reduction of nonspecific hybridization by using novel base-pairing schemes Methods are provided for substantially reducing background signals encountered in nucleic acid hybridization assays. The method is premised on the elimination or significant reduction of the phenomenon of nonspecific hybridization, so as to provide a dete... | 05/15/2001 |
| 6183779 | Stabilized pharmaceutical composition of a nonsteroidal anti-inflammatory agent and a prostaglandin A pharmaceutical composition is provided for the oral administration of an NSAID and a prostaglandin. The composition is a solid dosage form wherein the NSAID is enterically coated and the prostaglandin is present along with an effective stabilizing amoun... | 02/06/2001 |
| 6117446 | Drug dosage unit for buccal administration of steroidal active agents A buccal dosage unit is provided for administering a combination of steroidal active agents to a female individual. The novel buccal drug delivery systems may be used in female hormone replacement therapy, in female contraception, to treat female sexual d... | 09/12/2000 |
| 6117222 | Water-based, water-fast ink compositions containing a binder matrix of a monomeric polyacid and a monomeric polybase Water-based, water-fast ink compositions are provided. The compositions contain an aqueous liquid vehicle, a colorant, e.g., a pigment, dye or stain, and a binder material capable of ionically or physically entrapping the selected colorant. The binder mat... | 09/12/2000 |
| 6107452 | Thermally and/or photochemically crosslinked electroactive polymers in the manufacture of opto-electronic devices Preparation of thermally and/or photochemically crosslinkable oligomeric precursors and the use of those oligomeric precursors in preparing crosslinked electroactive polymers are described. The oligomers, polymers, and synthetic methods find utility in th... | 08/22/2000 |
| 6093181 | Treatment of erectile dysfunction Erectile dysfunction, particularly impotence, priapism and Peyronie's disease is treated by the transurethral administration of a therapeutically effective agent. The agents are administered to the urethra by means of a penile insert (1) having a rapidly ... | 07/25/2000 |
| 6090193 | Water-based ink compositions containing a binder material of a polymeric resin and a neutralizing composition Water-based, water-fast ink compositions are provided. The compositions contain an aqueous liquid vehicle, a colorant, e.g., a pigment, dye or stain, and a binder material capable of ionically or physically entrapping the selected colorant. Certain novel ... | 07/18/2000 |
| 6037360 | Administration of 5-HT3 receptor antagonists to treat premature ejaculation A method is provided for delaying the onset of ejaculation in an individual. The method involves administration of a 5-HT3 receptor antagonist within the context of an effective dosing regimen. The preferred mode of administration is transureth... | 03/14/2000 |
